Brian Weiner
Brian Weiner
Seres Therapeutics
Verified email at serestherapeutics.com - Homepage
Title
Cited by
Cited by
Year
Tuberculosis drug resistance mutation database
A Sandgren, M Strong, P Muthukrishnan, BK Weiner, GM Church, ...
PLoS Med 6 (2), e1000002, 2009
5782009
Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production
C Colijn, A Brandes, J Zucker, DS Lun, B Weiner, MR Farhat, TY Cheng, ...
PLoS Comput Biol 5 (8), e1000489, 2009
3832009
The Mycobacterium tuberculosis regulatory network and hypoxia
JE Galagan, K Minch, M Peterson, A Lyubetskaya, E Azizi, L Sweet, ...
Nature 499 (7457), 178-183, 2013
3652013
TB database: an integrated platform for tuberculosis research
TBK Reddy, R Riley, F Wymore, P Montgomery, D DeCaprio, R Engels, ...
Nucleic acids research 37 (suppl_1), D499-D508, 2009
2442009
HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes
MQ Hassan, R Tare, SH Lee, M Mandeville, B Weiner, M Montecino, ...
Molecular and cellular biology 27 (9), 3337-3352, 2007
1582007
TB database 2010: overview and update
JE Galagan, P Sisk, C Stolte, B Weiner, M Koehrsen, F Wymore, ...
Tuberculosis 90 (4), 225-235, 2010
1282010
SWI/SNF chromatin remodeling complex is obligatory for BMP2‐induced, Runx2‐dependent skeletal gene expression that controls osteoblast differentiation
DW Young, J Pratap, A Javed, B Weiner, Y Ohkawa, A Van Wijnen, ...
Journal of cellular biochemistry 94 (4), 720-730, 2005
882005
Comparative analysis of Mycobacterium and related Actinomycetes yields insight into the evolution of Mycobacterium tuberculosis pathogenesis
AM McGuire, B Weiner, ST Park, I Wapinski, S Raman, G Dolganov, ...
BMC genomics 13 (1), 1-27, 2012
812012
A blind deconvolution approach to high-resolution mapping of transcription factor binding sites from ChIP-seq data
DS Lun, A Sherrid, B Weiner, DR Sherman, JE Galagan
Genome biology 10 (12), 1-12, 2009
812009
Genome sequencing and analysis of geographically diverse clinical isolates of herpes simplex virus 2
RM Newman, SL Lamers, B Weiner, SC Ray, RC Colgrove, F Diaz, L Jing, ...
Journal of virology 89 (16), 8219-8232, 2015
632015
Pridopidine activates neuroprotective pathways impaired in Huntington Disease
M Geva, R Kusko, H Soares, KD Fowler, T Birnberg, S Barash, ...
Human molecular genetics 25 (18), 3975-3987, 2016
562016
Whole genome pyrosequencing of rare hepatitis C virus genotypes enhances subtype classification and identification of naturally occurring drug resistance variants
RM Newman, T Kuntzen, B Weiner, A Berical, P Charlebois, C Kuiken, ...
The Journal of infectious diseases 208 (1), 17-31, 2013
462013
Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy
JZ Li, B Chapman, P Charlebois, O Hofmann, B Weiner, AJ Porter, ...
PLoS One 9 (3), e90485, 2014
392014
Inferring carbon sources from gene expression profiles using metabolic flux models
A Brandes, DS Lun, K Ip, J Zucker, C Colijn, B Weiner, JE Galagan
PloS one 7 (5), e36947, 2012
312012
Independent large scale duplications in multiple M. tuberculosis lineages overlapping the same genomic region
B Weiner, J Gomez, TC Victor, RM Warren, A Sloutsky, BB Plikaytis, ...
PLoS One 7 (2), e26038, 2012
312012
A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis
CJ Ross, F Towfic, J Shankar, D Laifenfeld, M Thoma, M Davis, B Weiner, ...
Genome medicine 9 (1), 1-15, 2017
192017
Similarities and differences in properties of glatiramer acetate (Copaxone«, Teva) versus polimunol (Synthon) using standard and emerging technologies: P11190
A Komlosh, T Hasson, K Wells-Knecht, T Wells-Knecht, R Krispin, G Papir, ...
European Journal of Neurology 23, 2016
42016
Comparison of physicochemical, biological and genomic characteristics of differently manufactured glatiramoids to ensure MS patient safety
A Komlosh, T Hasson, K Wells-Knecht, T Molotsky, R Krispin, G Papir, ...
Multiple Sclerosis Journal 21, 687-688, 2015
32015
Laquinimod targets the aryl hydrocarbon receptor (AhR) pathway in periphery and brains of na´ve and EAE mice (P2. 365)
T Birnberg, J Kaye, K Fowler, B Weiner, I Caballero, S Barash, ...
Neurology 88 (16 Supplement), 2017
2017
Leveraging transcriptomic data to pinpoint mechanisms of gemcitabine resistance and potential combination therapies for pancreatic cancer.
RL Kusko, Y Cha, J Perez-Rogers, N Caballero, G Koytiger, J Shankar, ...
Journal of Clinical Oncology 34 (15_suppl), e15730-e15730, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20